-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The risk of premature death in patients with type 2 diabetes is 2-4 times that of patients with non-type 2 diabetes
.
Until recently, many studies reported that cancer is the second leading cause of death in patients with type 2 diabetes, and cardiovascular disease is the most common cause of death
Recently, Diabetes Obesity & Metabolism, an authoritative journal in the field of metabolic endocrine diseases, published a research article in which researchers aimed to evaluate the relationship between body mass index (BMI) and cancer mortality in patients with type 2 diabetes
.
The researchers used the clinical practice research data link GOLD (1998-2015) and linked it with the National Statistical Mortality Office to obtain a cohort of patients with type 2 diabetes (N=176886; age 30-85)
.
The researchers determined the diagnosis of diabetes during the BMI ± 12 months
During the annual follow-up of 886,850 person-times, 7,593 cancer deaths occurred in the study
.
In women who have never smoked, there is a positive correlation between BMI and endometrial death (HR per 5 kg/m 2 is 1.
Thus, the study found that there is some relationship between BMI and cancer mortality in patients with type 2 diabetes, but the interpretation of this association needs to consider smoking status, negative causality, and CVD death
.
.
Original source:
Nasra N Alam.
et al.
Body mass index and cancer mortality in patients with incident type 2 diabetes: a population-based study of adults in England.
Diabetes Obesity & Metabolism.
2021.
Original source: leave a message here